Rongpeng Li
- Endocrinology top 5%
- Cancer Research top 10%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 4
- Molecular Biology top 10%
- CRISPR and Genetic Engineering 7
- Bacterial biofilms and quorum sensing 5
- Inflammasome and immune disorders 5
- Genomics and Phylogenetic Studies 4
- RNA and protein synthesis mechanisms 4
- Molecular Medicine top 10%
-
- Autophagy in Disease and Therapy 11
- Journals
- Nature Communications (2 papers)Molecular Cell (1 paper)The Journal of Immunology (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Rongpeng Li
63 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 137
- Endocrinology 85
- Business and International Management 24
- Cancer Research 182
- Molecular Biology 818
- Molecular Medicine 56
Countries citing papers authored by Rongpeng Li
This map shows the geographic impact of Rongpeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongpeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongpeng Li more than expected).
Fields of papers citing papers by Rongpeng Li
This network shows the impact of papers produced by Rongpeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongpeng Li. The network helps show where Rongpeng Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rongpeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 53 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 15 | |
| 9 | 2021 | 8 | |
| 10 | 2020 | 23 | |
| 11 | 2020 | 70 | |
| 12 | 2020 | 23 | |
| 13 | 2019 | 32 | |
| 14 | 2018 | 79 | |
| 15 | 2017 | 28 | |
| 16 | 2016 | 46 | |
| 17 | 2016 | 19 | |
| 18 | 2016 | 57 | |
| 19 | 2015 | 13 | |
| 20 | 2013 | 2 |
About Rongpeng Li
Rongpeng Li is a scholar working on Microbiology, Cancer Research and Endocrinology, having authored 65 papers that have together received 1.8k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (11 papers), MicroRNA in disease regulation (8 papers), CRISPR and Genetic Engineering (7 papers), Bacterial biofilms and quorum sensing (5 papers), Inflammasome and immune disorders (5 papers), Genomics and Phylogenetic Studies (4 papers), Cancer-related molecular mechanisms research (4 papers) and RNA and protein synthesis mechanisms (4 papers). The work is most often cited by research in Endocrinology (85 citations), Business and International Management (24 citations) and Cancer Research (182 citations). Rongpeng Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Min Wu, Shirui Tan, Jianliang Zhang, Guangwei Wang, Min Yu, Yuquan Wei, Xuefeng Li, Qinqin Pu, Sisi He and Xiaojun Ning. Their work appears in journals such as Nature Communications, Molecular Cell and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.